{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:15:26Z","timestamp":1768256126607,"version":"3.49.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pheochromocytoma, as a neuroendocrine tumor with the highest genetic correlation in all types of tumors, has attracted extensive attention. Von Hipper Lindau (VHL) has the highest mutation frequency among the genes associated with pheochromocytoma. However, the effect of VHL on the proteome of pheochromocytoma remains to be explored. In this study, the VHL knockdown (VHL-KD) PC12 cell model was established by RNA interference (shRNA). We compared the proteomics of VHL-KD and VHL-WT PC12 cell lines. The results showed that the expression of 434 proteins (VHL shRNA\/WT &amp;gt; 1.3) changed significantly in VHL-KD-PC12 cells. Among the 434 kinds of proteins, 83 were involved in cell proliferation, cell cycle and cell migration, and so on. More importantly, among these proteins, we found seven novel key genes, including Connective Tissue Growth Factor (CTGF), Syndecan Binding Protein (SDCBP), Cysteine Rich Protein 61 (CYR61\/CCN1), Collagen Type III Alpha 1 Chain (COL3A1), Collagen Type I Alpha 1 Chain (COL1A1), Collagen Type V Alpha 2 Chain (COL5A2), and Serpin Family E Member 1 (SERPINE1), were overexpressed and simultaneously regulated cell proliferation and migration in VHL-KD PC12 cells. Furthermore, the abnormal accumulation of HIF2\u03b1 caused by VHL-KD significantly increased the expression of these seven genes during hypoxia. Moreover, cell-counting, scratch, and transwell assays demonstrated that VHL-KD could promote cell proliferation and migration, and changed cell morphology. These findings indicated that inhibition of VHL expression could promote the development of pheochromocytoma by activating the expression of cell proliferation and migration associated genes.<\/jats:p>","DOI":"10.3389\/fendo.2021.598656","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T16:13:30Z","timestamp":1616429610000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Seven Novel Genes Related to Cell Proliferation and Migration of VHL-Mutated Pheochromocytoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuai","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feizhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180151","article-title":"Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes","volume":"39","author":"Withey","year":"2019","journal-title":"Radiographics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101347","article-title":"Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies","volume":"34","author":"Schreiner","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101416","article-title":"An overview of 20\u00a0years of genetic studies in pheochromocytoma and paraganglioma","volume":"34","author":"Buffet","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101505","article-title":"Practicing Clinician in the Era of Precision Medicine","volume":"11","author":"N\u00f6lting","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.161353","article-title":"Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma","volume":"128","author":"Song","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.12.7015","article-title":"Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas","volume":"85","author":"Bender","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.08.001","article-title":"New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma","volume":"28","author":"Ta\u00efeb","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32835fcc45","article-title":"Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options","volume":"20","author":"Vicha","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207669","article-title":"Head and Neck Paragangliomas-A Genetic Overview","volume":"21","author":"Majewska","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12022-012-9199-6","article-title":"Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies","volume":"23","author":"N\u00f6lting","year":"2012","journal-title":"Endocr Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/pap.0000000000000086","article-title":"Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy","volume":"22","author":"Guo","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.586857","article-title":"The VHL\/HIF Axis in the Development and Treatment of Pheochromocytoma\/Paraganglioma","volume":"11","author":"Peng","year":"2020","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.21.3.865-874.2001","article-title":"VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling","volume":"21","author":"Davidowitz","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biomedicines6010035","article-title":"VHL and Hypoxia Signaling: Beyond HIF in Cancer","volume":"6","author":"Zhang","year":"2018","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci STKE"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-005-1262-y","article-title":"Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas","volume":"447","author":"Atkins","year":"2005","journal-title":"Virchows Arch"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/BF01517220","article-title":"Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene","volume":"55","author":"Chen","year":"1995","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/erc-20-0205","article-title":"HIF2\u03b1 supports pro-metastatic behavior in pheochromocytomas\/paragangliomas","volume":"27","author":"Bechmann","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2014.021","article-title":"A new twist in neuroendocrine tumor research: Pacak-Zhuang syndrome, HIF-2\u03b1 as the major player in its pathogenesis and future therapeutic options","volume":"158","author":"Jochmanova","year":"2014","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073123","article-title":"A gain-of-function mutation in the HIF2A gene in familial erythrocytosis","volume":"358","author":"Percy","year":"2008","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1983-y","article-title":"Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas","volume":"126","author":"Ta\u00efeb","year":"2016","journal-title":"J Neurooncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-137703","article-title":"Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis","volume":"111","author":"Percy","year":"2008","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1217","article-title":"First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome","volume":"98","author":"Ta\u00efeb","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-460972","article-title":"Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas","volume":"121","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMc1211953","article-title":"HIF2A mutations in paraganglioma with polycythemia","volume":"367","author":"Favier","year":"2012","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt069","article-title":"Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis","volume":"22","author":"Comino-M\u00e9ndez","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/erc-13-0101","article-title":"In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas","volume":"20","author":"Toledo","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/b978-0-12-411512-5.00014-2","article-title":"Role of hypoxia and HIF2\u03b1 in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features","volume":"68","author":"Richter","year":"2013","journal-title":"Adv Pharmacol (San Diego Calif)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","author":"Lorenzo","year":"2013","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"Tian","year":"1998","journal-title":"Genes Dev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.10.003","article-title":"HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia","volume":"303","author":"Nilsson","year":"2005","journal-title":"Exp Cell Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.021667","article-title":"Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice","volume":"8","author":"Huang","year":"2015","journal-title":"Dis Models Mech"},{"key":"B41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/01.pai.0000145182.98577.10","article-title":"Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas","volume":"14","author":"Giatromanolaki","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.38.6797","article-title":"Von hippel-lindau disease and erythrocytosis","volume":"30","author":"Capodimonti","year":"2012","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1088\/1748-605X\/aae7ba","article-title":"Guided cell adhesion, orientation, morphology and differentiation on silicon substrates photolithographically micropatterned with a cell-repellent cross-linked poly(vinyl alcohol) film","volume":"14","author":"Bourkoula","year":"2018","journal-title":"BioMed Mater"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.0c00591","article-title":"Post-Thaw Culture and Measurement of Total Cell Recovery Is Crucial in the Evaluation of New Macromolecular Cryoprotectants","volume":"21","author":"Murray","year":"2020","journal-title":"Biomacromolecules"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300383","article-title":"Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture","volume":"16","author":"Broussau","year":"2008","journal-title":"Mol Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.03.006","article-title":"Mortality associated with pheochromocytoma in a large Swedish cohort","volume":"30","author":"Khorram-Manesh","year":"2004","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9328","article-title":"Never-in-mitosis A-related kinase 8, a novel target of von-Hippel-Lindau tumor suppressor protein, promotes gastric cancer cell proliferation","volume":"16","author":"Ding","year":"2018","journal-title":"Oncol Lett"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2019.04.003","article-title":"Emerging molecular markers of metastatic pheochromocytomas and paragangliomas","volume":"80","author":"Goncalves","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1055\/a-0715-1888","article-title":"Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options","volume":"127","author":"N\u00f6lting","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/cancers12030599","article-title":"Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas\/Paragangliomas","volume":"12","author":"Sarkadi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular targeted therapy: Treating cancer with specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40618-017-0683-1","article-title":"Von Hippel-Lindau disease: a single gene, several hereditary tumors","volume":"41","author":"Crespigio","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-444-62702-5.00010-x","article-title":"Von Hippel-Lindau disease","volume":"132","author":"Chittiboina","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.338","article-title":"The HIF and other quandaries in VHL disease","volume":"37","author":"Tarade","year":"2018","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081774","article-title":"Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma","volume":"18","author":"Mehdi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000243","article-title":"E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation","volume":"205","author":"Chitrakar","year":"2020","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181211","article-title":"The E3 ligase VHL controls alveolar macrophage function via metabolic-epigenetic regulation","volume":"215","author":"Zhang","year":"2018","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.immuni.2017.12.013","article-title":"E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor","volume":"48","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1291-7","article-title":"VHL-HIF-2\u03b1 axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111845","article-title":"ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma","volume":"388","author":"Persson","year":"2020","journal-title":"Exp Cell Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1038\/s41467-020-17873-3","article-title":"HIF-1\u03b1 and HIF-2\u03b1 differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice","volume":"11","author":"Hoefflin","year":"2020","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2020.61.1.20","article-title":"Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21\/VHL Axis","volume":"61","author":"Chen","year":"2020","journal-title":"Yonsei Med J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13046-020-01609-8","article-title":"VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt\/GSK-3\u03b2 signaling","volume":"39","author":"Sun","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/1120009x.2019.1687996","article-title":"SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT","volume":"31","author":"Yang","year":"2019","journal-title":"J Chemother"},{"key":"B66","article-title":"Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595","volume-title":"Molecular Imaging and Contrast Agent Database (MICAD)","author":"Leung","year":"2004"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104695","article-title":"MDA-9\/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis","volume":"155","author":"Das","year":"2020","journal-title":"Pharmacol Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/1535-7163.Mct-18-1019","article-title":"Suppression of Prostate Cancer Pathogenesis Using an MDA-9\/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor","volume":"18","author":"Das","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10637-020-00980-9","article-title":"Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics","volume":"9","author":"Chen","year":"2020","journal-title":"Invest New Drugs"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/s1875-5364(20)30073-x","article-title":"Early intervention with Di-Dang Decoction prevents macrovascular fibrosis in diabetic rats by regulating the TGF-\u03b21\/Smad signalling pathway","volume":"18","author":"Zhou","year":"2020","journal-title":"Chin J Natural Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101076","article-title":"Dynamic Malignant Wave of Ribosome-Insulted Gut Niche via the Wnt-CTGF\/CCN2 Circuit","volume":"23","author":"Kim","year":"2020","journal-title":"iScience"},{"key":"B72","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/cancers11060786","article-title":"Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis","volume":"11","author":"Ma","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.05.092","article-title":"MRTF-A mediates the activation of COL1A1 expression stimulated by multiple signaling pathways in human breast cancer cells","volume":"104","author":"Meng","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12957-016-1056-5","article-title":"Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer","volume":"14","author":"Li","year":"2016","journal-title":"World J Surg Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/jca.45378","article-title":"The prognostic value of COL3A1\/FBN1\/COL5A2\/SPARC-mir-29a-3p-H19 associated ceRNA network in Gastric Cancer through bioinformatic exploration","volume":"11","author":"Shen","year":"2020","journal-title":"J Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151070","article-title":"Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells","volume":"99","author":"Ilhan","year":"2020","journal-title":"Eur J Cell Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.598656\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T16:13:35Z","timestamp":1616429615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.598656\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":76,"alternative-id":["10.3389\/fendo.2021.598656"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.598656","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"article-number":"598656"}}